277 related articles for article (PubMed ID: 35563777)
1. Obesity-Associated Cancers: Evidence from Studies in Mouse Models.
Lee H
Cells; 2022 Apr; 11(9):. PubMed ID: 35563777
[TBL] [Abstract][Full Text] [Related]
2. Diabetes, Obesity, and Breast Cancer.
Kang C; LeRoith D; Gallagher EJ
Endocrinology; 2018 Nov; 159(11):3801-3812. PubMed ID: 30215698
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress associated to dysfunctional adipose tissue: a potential link between obesity, type 2 diabetes mellitus and breast cancer.
Crujeiras AB; Díaz-Lagares A; Carreira MC; Amil M; Casanueva FF
Free Radic Res; 2013 Apr; 47(4):243-56. PubMed ID: 23409968
[TBL] [Abstract][Full Text] [Related]
4. Novel Insights into the Adipokinome of Obese and Obese/Diabetic Mouse Models.
Knebel B; Goeddeke S; Poschmann G; Markgraf DF; Jacob S; Nitzgen U; Passlack W; Preuss C; Dicken HD; Stühler K; Hartwig S; Lehr S; Kotzka J
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885548
[TBL] [Abstract][Full Text] [Related]
5. C57BL/KsJ-db/db-Apc mice exhibit an increased incidence of intestinal neoplasms.
Hata K; Kubota M; Shimizu M; Moriwaki H; Kuno T; Tanaka T; Hara A; Hirose Y
Int J Mol Sci; 2011; 12(11):8133-45. PubMed ID: 22174655
[TBL] [Abstract][Full Text] [Related]
6. Effects of obesity on transcriptomic changes and cancer hallmarks in estrogen receptor-positive breast cancer.
Fuentes-Mattei E; Velazquez-Torres G; Phan L; Zhang F; Chou PC; Shin JH; Choi HH; Chen JS; Zhao R; Chen J; Gully C; Carlock C; Qi Y; Zhang Y; Wu Y; Esteva FJ; Luo Y; McKeehan WL; Ensor J; Hortobagyi GN; Pusztai L; Fraser Symmans W; Lee MH; Yeung SC
J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 24957076
[TBL] [Abstract][Full Text] [Related]
7. Exploring the endocannabinoidome in genetically obese (ob/ob) and diabetic (db/db) mice: Links with inflammation and gut microbiota.
Suriano F; Manca C; Flamand N; Depommier C; Van Hul M; Delzenne NM; Silvestri C; Cani PD; Di Marzo V
Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Jan; 1867(1):159056. PubMed ID: 34606993
[TBL] [Abstract][Full Text] [Related]
8. From obesity to cancer: a review on proposed mechanisms.
Tahergorabi Z; Khazaei M; Moodi M; Chamani E
Cell Biochem Funct; 2016 Dec; 34(8):533-545. PubMed ID: 27859423
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Syndrome, Type 2 Diabetes, and Cancer: Epidemiology and Potential Mechanisms.
Ben-Shmuel S; Rostoker R; Scheinman EJ; LeRoith D
Handb Exp Pharmacol; 2016; 233():355-72. PubMed ID: 25903410
[TBL] [Abstract][Full Text] [Related]
10. Recent insights on modulation of inflammasomes by adipokines: a critical event for the pathogenesis of obesity and metabolism-associated diseases.
Pham DV; Park PH
Arch Pharm Res; 2020 Oct; 43(10):997-1016. PubMed ID: 33078304
[TBL] [Abstract][Full Text] [Related]
11. Type 2 diabetes and obesity metabolic interactions: common factors for breast cancer risk and novel approaches to prevention and therapy.
Vona-Davis L; Rose DP
Curr Diabetes Rev; 2012 Mar; 8(2):116-30. PubMed ID: 22268396
[TBL] [Abstract][Full Text] [Related]
12. Obesity Biomarkers, Metabolism and Risk of Cancer: An Epidemiological Perspective.
Nimptsch K; Pischon T
Recent Results Cancer Res; 2016; 208():199-217. PubMed ID: 27909909
[TBL] [Abstract][Full Text] [Related]
13. Insulin and IGFs in obesity-related breast cancer.
Belardi V; Gallagher EJ; Novosyadlyy R; LeRoith D
J Mammary Gland Biol Neoplasia; 2013 Dec; 18(3-4):277-89. PubMed ID: 24154546
[TBL] [Abstract][Full Text] [Related]
14. Accelerated tumor formation in a fatless mouse with type 2 diabetes and inflammation.
Nunez NP; Oh WJ; Rozenberg J; Perella C; Anver M; Barrett JC; Perkins SN; Berrigan D; Moitra J; Varticovski L; Hursting SD; Vinson C
Cancer Res; 2006 May; 66(10):5469-76. PubMed ID: 16707476
[TBL] [Abstract][Full Text] [Related]
15. Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin.
Sahai A; Malladi P; Pan X; Paul R; Melin-Aldana H; Green RM; Whitington PF
Am J Physiol Gastrointest Liver Physiol; 2004 Nov; 287(5):G1035-43. PubMed ID: 15256362
[TBL] [Abstract][Full Text] [Related]
16. The Role of Adipokines in Breast Cancer: Current Evidence and Perspectives.
Christodoulatos GS; Spyrou N; Kadillari J; Psallida S; Dalamaga M
Curr Obes Rep; 2019 Dec; 8(4):413-433. PubMed ID: 31637624
[TBL] [Abstract][Full Text] [Related]
17. Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets.
Khan S; Shukla S; Sinha S; Meeran SM
Cytokine Growth Factor Rev; 2013 Dec; 24(6):503-13. PubMed ID: 24210902
[TBL] [Abstract][Full Text] [Related]
18. Should adipokines be considered in the choice of the treatment of obesity-related health problems?
Athyros VG; Tziomalos K; Karagiannis A; Anagnostis P; Mikhailidis DP
Curr Drug Targets; 2010 Jan; 11(1):122-35. PubMed ID: 20017725
[TBL] [Abstract][Full Text] [Related]
19. Involvement of inflammatory factors in pancreatic carcinogenesis and preventive effects of anti-inflammatory agents.
Takahashi M; Mutoh M; Ishigamori R; Fujii G; Imai T
Semin Immunopathol; 2013 Mar; 35(2):203-27. PubMed ID: 22955327
[TBL] [Abstract][Full Text] [Related]
20. All in the family: Clueing into the link between metabolic syndrome and hematologic malignancies.
Karmali R; Dalovisio A; Borgia JA; Venugopal P; Kim BW; Grant-Szymanski K; Hari P; Lazarus H
Blood Rev; 2015 Mar; 29(2):71-80. PubMed ID: 25433571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
